glp-1 and gip hormones Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management Glucagon-like peptide (GLP)-1 and GLP-2

Glutathione workshop [PMID: 5800594] Laboratory literature summary: Glutathione workshop

Next-generation multimodal agonists combine GLP-1 activity with other incretin or metabolic targets

Formulations of L-carnitine L-Carnitine is available in some countries as an oral preparation (1 g/10 ml solution, 330 mg tablets) or as an injectable drug (intramuscular or intravenous, 1 g/5 ml solution

From insulin to GLP-1 medications, peptides have consistently pushed the boundaries of health and treatment

Antagonistic effects: One nutrient reduces the absorption of another, potentially leading to deficiencies

An older 1996 study reported a half-life of around 6669 hours after an oral dose, which is dramatically longer